Literature DB >> 15340079

Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.

Eugenia Trushina1, Roy B Dyer, John D Badger, Daren Ure, Lars Eide, David D Tran, Brent T Vrieze, Valerie Legendre-Guillemin, Peter S McPherson, Bhaskar S Mandavilli, Bennett Van Houten, Scott Zeitlin, Mark McNiven, Ruedi Aebersold, Michael Hayden, Joseph E Parisi, Erling Seeberg, Ioannis Dragatsis, Kelly Doyle, Anna Bender, Celin Chacko, Cynthia T McMurray.   

Abstract

Recent data in invertebrates demonstrated that huntingtin (htt) is essential for fast axonal trafficking. Here, we provide direct and functional evidence that htt is involved in fast axonal trafficking in mammals. Moreover, expression of full-length mutant htt (mhtt) impairs vesicular and mitochondrial trafficking in mammalian neurons in vitro and in whole animals in vivo. Particularly, mitochondria become progressively immobilized and stop more frequently in neurons from transgenic animals. These defects occurred early in development prior to the onset of measurable neurological or mitochondrial abnormalities. Consistent with a progressive loss of function, wild-type htt, trafficking motors, and mitochondrial components were selectively sequestered by mhtt in human Huntington's disease-affected brain. Data provide a model for how loss of htt function causes toxicity; mhtt-mediated aggregation sequesters htt and components of trafficking machinery leading to loss of mitochondrial motility and eventual mitochondrial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340079      PMCID: PMC515048          DOI: 10.1128/MCB.24.18.8195-8209.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Polyglutamine-mediated aggregation and cell death.

Authors:  T de Cristofaro; A Affaitati; A Feliciello; E V Avvedimento; S Varrone
Journal:  Biochem Biophys Res Commun       Date:  2000-06-16       Impact factor: 3.575

2.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Analysis of gene-specific DNA damage and repair using quantitative polymerase chain reaction.

Authors:  S Ayala-Torres; Y Chen; T Svoboda; J Rosenblatt; B Van Houten
Journal:  Methods       Date:  2000-10       Impact factor: 3.608

4.  Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport.

Authors:  Györgyi Szebenyi; Gerardo A Morfini; Alyssa Babcock; Milena Gould; Kimberly Selkoe; David L Stenoien; Maureen Young; Pieter W Faber; Marcy E MacDonald; Michael J McPhaul; Scott T Brady
Journal:  Neuron       Date:  2003-09-25       Impact factor: 17.173

Review 5.  Molecular basis of Alzheimer's disease.

Authors:  B Drouet; M Pinçon-Raymond; J Chambaz; T Pillot
Journal:  Cell Mol Life Sci       Date:  2000-05       Impact factor: 9.261

Review 6.  The role of mitochondria in the pathogenesis of neurodegenerative diseases.

Authors:  G Manfredi; M F Beal
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

7.  Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.

Authors:  V C Wheeler; J K White; C A Gutekunst; V Vrbanac; M Weaver; X J Li; S H Li; H Yi; J P Vonsattel; J F Gusella; S Hersch; W Auerbach; A L Joyner; M E MacDonald
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

Review 8.  The hunt for huntingtin function: interaction partners tell many different stories.

Authors:  Phoebe Harjes; Erich E Wanker
Journal:  Trends Biochem Sci       Date:  2003-08       Impact factor: 13.807

9.  Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila.

Authors:  Shermali Gunawardena; Lu-Shiun Her; Richard G Brusch; Robert A Laymon; Ingrid R Niesman; Beth Gordesky-Gold; Louis Sintasath; Nancy M Bonini; Lawrence S B Goldstein
Journal:  Neuron       Date:  2003-09-25       Impact factor: 17.173

10.  Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.

Authors:  Chiara Zuccato; Marzia Tartari; Andrea Crotti; Donato Goffredo; Marta Valenza; Luciano Conti; Tiziana Cataudella; Blair R Leavitt; Michael R Hayden; Tõnis Timmusk; Dorotea Rigamonti; Elena Cattaneo
Journal:  Nat Genet       Date:  2003-07-27       Impact factor: 38.330

View more
  202 in total

Review 1.  Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration.

Authors:  Jorge M A Oliveira
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

2.  Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease.

Authors:  Kuan-Yu Liu; Yu-Chiau Shyu; Brett A Barbaro; Yuan-Ta Lin; Yijuang Chern; Leslie Michels Thompson; Che-Kun James Shen; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2014-11-14       Impact factor: 6.150

3.  Local motion analysis reveals impact of the dynamic cytoskeleton on intracellular subdiffusion.

Authors:  Marcus Otten; Amitabha Nandi; Delphine Arcizet; Mari Gorelashvili; Benjamin Lindner; Doris Heinrich
Journal:  Biophys J       Date:  2012-02-21       Impact factor: 4.033

4.  The Huntington's disease mutation impairs Huntingtin's role in the transport of NF-κB from the synapse to the nucleus.

Authors:  Edoardo Marcora; Mary B Kennedy
Journal:  Hum Mol Genet       Date:  2010-08-25       Impact factor: 6.150

Review 5.  Retrograde axonal transport: pathways to cell death?

Authors:  Eran Perlson; Sandra Maday; Meng-Meng Fu; Armen J Moughamian; Erika L F Holzbaur
Journal:  Trends Neurosci       Date:  2010-04-29       Impact factor: 13.837

Review 6.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

7.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

Review 8.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 9.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

Review 10.  Mutant huntingtin and mitochondrial dysfunction.

Authors:  Ella Bossy-Wetzel; Alejandra Petrilli; Andrew B Knott
Journal:  Trends Neurosci       Date:  2008-10-24       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.